Zuckerman Investment Group’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$276K Buy
+1,205
New +$218K 0.02% 124
2026
Q1
Sell
-1,205
Closed -$209K 144
2025
Q4
$209K Hold
1,205
0.02% 130
2025
Q3
$231K Hold
1,205
0.02% 141
2025
Q2
$359K Hold
1,205
0.03% 121
2025
Q1
$397K Sell
1,205
-115
-9% -$34.7K 0.04% 122
2024
Q4
$429K Sell
1,320
-810
-38% -$250K 0.04% 114
2024
Q3
$734K Hold
2,130
0.08% 81
2024
Q2
$633K Hold
2,130
0.07% 86
2024
Q1
$875K Hold
2,130
0.1% 73
2023
Q4
$770K Hold
2,130
0.1% 76
2023
Q3
$698K Hold
2,130
0.1% 67
2023
Q2
$642K Hold
2,130
0.09% 70
2023
Q1
$570K Hold
2,130
0.09% 75
2022
Q4
$703K Sell
2,130
-330
-13% -$112K 0.11% 67
2022
Q3
$811K Buy
+2,460
New +$792K 0.15% 61

Other funds holding MOH

Zuckerman Investment Group's MOH Position: Q2 2026 in Review

Zuckerman Investment Group opened a new position in Molina Healthcare (MOH) in Q2 2026: 1,205 shares worth $276K. The stake represents 0.02% of the portfolio and ranks #124 among its holdings. This is a return to the name: Zuckerman Investment Group previously reported a position in MOH as recently as Q4 2025.

Zuckerman Investment Group first reported a position in MOH in Q3 2022 and has held it in 15 quarters since. The position peaked at $875K in Q1 2024. 601 funds tracked by Wall St. Rank hold MOH as of Q2 2026.

  • Zuckerman Investment Group held 1,205 shares of Molina Healthcare worth $276K as of Q2 2026.
  • Molina Healthcare was a new Zuckerman Investment Group position in Q2 2026.
  • Molina Healthcare made up 0.02% of Zuckerman Investment Group's portfolio in Q2 2026, its #124 holding.
  • Zuckerman Investment Group first reported a position in Molina Healthcare in Q3 2022 and has held it in 15 quarters since.
  • Zuckerman Investment Group's Molina Healthcare position peaked at $875K in Q1 2024.
  • 601 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.

Based on Zuckerman Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.